REBECCA LYNN JOHNSON M.D. NPI 1023428828

NPI Details

Rebecca Lynn Johnson, M.D. is an anatomic pathology and clinical pathology pathology in Chico, CA with 16 years of experience. The provider is a pathologist deals with the causes and nature of disease and contributes to diagnosis, prognosis and treatment through knowledge gained by the laboratory application of the biologic, chemical and physical sciences. A pathologist uses information gathered from the microscopic examination of tissue specimens, cells and body fluids, and from clinical laboratory tests on body fluids and secretions for the diagnosis, exclusion and monitoring of disease. Rebecca Lynn Johnson, M.D. NPI is 1023428828. The provider is registered as an individual entity type.

The NPPES NPI record indicates the provider is a female.

Education
Medical School: UNIVERSITY OF MINNESOTA MEDICAL SCHOOL
Graduation Year:2010

The provider's business location address is:

183 E 8TH AVE
CHICO, CA
ZIP 95926-341
Phone: (530) 891-6244
Fax: (530) 891-0134

The NPI 1023428828 is registered in the Medicare Provider, Enrollment, Chain and Ownership System (PECOS). The provider is legally eligible to order and refer Part B (Clinical Laboratory and Imaging), Durable Medical Equipment, Part A Home Health Agency (HHA), Power Mobility Devices.

The following top HCPCS codes were publicly reported for this provider under the Medicare program for the year 2016. The reported codes are based on the top codes for each available Medicare specialty, excluding evaluation and management codes.

• Pathology examination of tissue using a microscope, intermediate complexity (HCPCS:88305)
• Infectious agent detection by nucleic acid (dna or rna); severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), amplified probe technique, making use of high throughput technologies as described by cms-2020-01-r (HCPCS:U0003)
• Infectious agent detection by nucleic acid (dna or rna); severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), amplified probe technique, cdc or non-cdc, making use of high throughput technologies, completed within (HCPCS:U0005)
• Screening cytopathology, cervical or vaginal (any reporting system), collected in preservative fluid, automated thin layer preparation, with screening by automated system and manual rescreening under physician supervision (HCPCS:G0145)
• Special stained specimen slides to examine tissue, each additional procedure (HCPCS:88341)
• Detection test for candida species (yeast), amplified probe technique (HCPCS:87481)
• Infectious agent detection by nucleic acid (dna or rna); human papillomavirus (hpv), high-risk types (e.g., 16, 18, 31, 33, 35, 39, 45, 51, 52, 56, 58, 59, 68) for cervical cancer screening, must be performed in addition to pap test (HCPCS:G0476)
• Special stained specimen slides to examine tissue, initial procedure (HCPCS:88342)
• Microscopic genetic analysis of tumor, manual (HCPCS:88360)
• Microscopic genetic analysis of tissue, computer-assisted technology, initial procedure, each multiplex procedure (HCPCS:88374)
• Flow cytometry technique for dna or cell analysis, 16 or more markers (HCPCS:88189)
• Measurement of dna of bacteria in vaginal fluid specimen (HCPCS:81514)
• Detection test by nucleic acid for trichomonas vaginalis (genital parasite), amplified probe technique (HCPCS:87661)
• Detection test by nucleic acid for multiple organisms, amplified probe(s) technique (HCPCS:87801)
• Special stained specimen slides to examine tissue including interpretation and report (HCPCS:88313)
• Pathology examination of tissue using a microscope, moderately high complexity (HCPCS:88307)
• Preparation of tissue for examination by removing any calcium present (HCPCS:88311)
• Evaluation of fine needle aspirate (HCPCS:88172)
• Pathology examination of tissue using a microscope, moderately low complexity (HCPCS:88304)
• Special stained specimen slides to identify organisms including interpretation and report (HCPCS:88312)
• Bone marrow, smear interpretation (HCPCS:85097)
• Detection test by nucleic acid for human papillomavirus (hpv), high-risk types (HCPCS:87624)
• Pap test, automated thin layer preparation; automated system and manual rescreening (HCPCS:88175)
• Evaluation of fine needle aspirate with interpretation and report (HCPCS:88173)
• Cell examination of specimen, selective cellular enhancement technique (HCPCS:88112)
• Screening cytopathology, cervical or vaginal (any reporting system), collected in preservative fluid, automated thin layer preparation, screening by cytotechnologist under physician supervision (HCPCS:G0123)
• Examination of archival tissue for genetic analysis (HCPCS:88363)
• Screening cytopathology, cervical or vaginal (any reporting system), collected in preservative fluid, automated thin layer preparation, requiring interpretation by physician (HCPCS:G0124)
• Pathology examination of specimen during surgery, first tissue block (HCPCS:88331)
• Pathology examination of tissue using a microscope, limited examination (HCPCS:88300)
• Microscopic genetic analysis of tissue, manual, each additional multiplex stain procedure (HCPCS:88377)
• Pap test (HCPCS:88141)
• Surgical pathology, gross and microscopic examinations, for prostate needle biopsy, any method (HCPCS:G0416)
• Special stained specimen slides to examine tissue, each multiplex procedure (HCPCS:88344)
• Genetic sequencing localization, initial procedure (HCPCS:88365)
• Genetic sequencing localization, each additional procedure (HCPCS:88364)
• Flow cytometry technique for dna or cell analysis, 9 to 15 markers (HCPCS:88188)
• Pap test, manual screening (HCPCS:88142)
• Pathology examination of tissue using a microscope, high complexity (HCPCS:88309)

The enumeration date for this NPI number is 5/1/2014 and was last updated on 6/6/2016.

Taxonomy Codes

The NPI record includes the healthcare provider taxonomy classification, state license number and state of licensure. The following information regarding the scope of practice of this provider is available: